ATE122035T1 - Naphthylethylharnstoff und naphthylethylthioharnstoff verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. - Google Patents
Naphthylethylharnstoff und naphthylethylthioharnstoff verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.Info
- Publication number
- ATE122035T1 ATE122035T1 AT92402321T AT92402321T ATE122035T1 AT E122035 T1 ATE122035 T1 AT E122035T1 AT 92402321 T AT92402321 T AT 92402321T AT 92402321 T AT92402321 T AT 92402321T AT E122035 T1 ATE122035 T1 AT E122035T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- naphthylethylthiourea
- naphthylethyl
- urea
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
- C07C335/10—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C335/12—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9110547A FR2680507B1 (fr) | 1991-08-23 | 1991-08-23 | Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE122035T1 true ATE122035T1 (de) | 1995-05-15 |
Family
ID=9416355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92402321T ATE122035T1 (de) | 1991-08-23 | 1992-08-21 | Naphthylethylharnstoff und naphthylethylthioharnstoff verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. |
Country Status (12)
Country | Link |
---|---|
US (4) | US5389683A (de) |
EP (1) | EP0530087B1 (de) |
JP (1) | JPH0780831B2 (de) |
AT (1) | ATE122035T1 (de) |
AU (1) | AU646968B2 (de) |
CA (1) | CA2076589C (de) |
DE (1) | DE69202313T2 (de) |
DK (1) | DK0530087T3 (de) |
ES (1) | ES2074846T3 (de) |
FR (1) | FR2680507B1 (de) |
NZ (1) | NZ244051A (de) |
ZA (1) | ZA926328B (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2680507B1 (fr) * | 1991-08-23 | 1993-10-08 | Adir Cie | Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
NZ273741A (en) * | 1993-08-24 | 2000-06-23 | Medivir Ab | Heterocyclically-substituted guanidine, urea and thiourea derivatives |
FR2713636B1 (fr) * | 1993-12-07 | 1996-01-05 | Adir | Nouveaux dérivés naphtaléniques, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent. |
AU2109695A (en) | 1994-03-30 | 1995-10-23 | Novartis Ag | Screening method using the rzr receptor family |
US5849769A (en) * | 1994-08-24 | 1998-12-15 | Medivir Ab | N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection |
US6235789B1 (en) | 1994-09-12 | 2001-05-22 | Takeda Chemical Industries, Ltd. | Benzocycloalkene compounds, their production and use |
US5541228A (en) * | 1994-10-14 | 1996-07-30 | Bristol-Myers Squibb Co. | Melatonergic agents |
US6071946A (en) * | 1994-10-21 | 2000-06-06 | Adir Et Compagnie | Tricyclic urea compounds |
FR2725985B1 (fr) * | 1994-10-21 | 1996-11-15 | Adir | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US5998461A (en) * | 1994-10-21 | 1999-12-07 | Adir Et Compagnie | Tricyclic amide compounds |
US5530012A (en) | 1994-12-22 | 1996-06-25 | Bristol-Myers Squibb Co. | 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
FR2729147A1 (fr) * | 1995-01-11 | 1996-07-12 | Adir | Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US5661186A (en) * | 1995-02-24 | 1997-08-26 | Bristol-Myers Squibb Co. | Tetralinyl-and indanyl-ethylamides |
FR2734815B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes arylalkyl (thio) carboxamides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
FR2734814B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2741799B1 (fr) * | 1995-12-04 | 1998-01-02 | Oreal | Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue |
FR2741802B1 (fr) * | 1995-12-04 | 1998-01-02 | Oreal | Utilisation de melatonine pour traiter les peaux sensibles |
US5808151A (en) * | 1996-04-17 | 1998-09-15 | Bristol-Myers Squibb Company | Biphenylamido derivatives as melatonergic agents |
AUPO274596A0 (en) * | 1996-10-04 | 1996-10-31 | Armstrong, Stuart Maxwell | Method for the treatment of neurological or neuropsychiatric disorders |
CZ297673B6 (cs) * | 1996-12-10 | 2007-02-28 | Bristol-Myers Squibb Company | Benzodioxolová, benzofuranová, dihydrobenzofuranová a benzodioxanová melatonergická cinidla |
US5958964A (en) * | 1997-02-18 | 1999-09-28 | South Alabama Medical Science Foundation | Use of melatonin to prevent cytotoxic effects of amyloid beta protein |
US6028112A (en) * | 1997-05-23 | 2000-02-22 | Bristol-Myers Squibb Company | Spirocyclopropyl fluorenes as melatonergic agents |
FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP4989830B2 (ja) * | 1999-07-21 | 2012-08-01 | サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク | 脳によるグルタミン酸塩の放出に対して抑制効果を示す薬剤を製造するためのベータ−ナフトキノン誘導体の使用 |
IL144900A (en) | 2001-08-14 | 2013-12-31 | Neurim Pharma 1991 | Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs |
WO2004012695A1 (en) * | 2002-08-02 | 2004-02-12 | Arye Rubinstein | The use of alkylureas for treating acne |
FR2848850B1 (fr) * | 2002-12-20 | 2005-06-24 | Guerbet Sa | Nouvelles compositions de particules magnetiques recouvertes de derives gem-bisphosphonates. |
US20050272819A1 (en) * | 2003-07-31 | 2005-12-08 | Arye Rubinstein | Use of alkylureas for treating acne |
EP2909166A4 (de) * | 2012-10-22 | 2016-10-26 | Symed Labs Ltd | Prozesse zur herstellung von agomelatin mithilfe neuartiger zwischenstoffe |
CN104276979B (zh) * | 2013-07-10 | 2018-09-07 | 江苏豪森药业集团有限公司 | 阿戈美拉汀中间体的制备方法 |
WO2022022542A1 (zh) * | 2020-07-28 | 2022-02-03 | 上海翰森生物医药科技有限公司 | 双环类衍生物调节剂、其制备方法和应用 |
CN117377777A (zh) | 2021-05-11 | 2024-01-09 | 纽瑞姆制药(1991)有限公司 | 诊断和治疗具有2号染色体2:107,510,000-107,540,000基因座单核苷酸多态性受试者的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH490003A (de) * | 1966-03-08 | 1970-05-15 | Ciba Geigy | Molluskizides Mittel |
DE68911203T2 (de) * | 1988-03-30 | 1994-04-14 | Warner Lambert Co | N-[[(2,6-disubstituierte)phenyl]N'- arylalkyl] Harnstoffe als antihypercholesterolemische und antiatherosclerotische Mittel. |
FR2680507B1 (fr) * | 1991-08-23 | 1993-10-08 | Adir Cie | Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1991
- 1991-08-23 FR FR9110547A patent/FR2680507B1/fr not_active Expired - Fee Related
-
1992
- 1992-08-14 US US07/930,285 patent/US5389683A/en not_active Expired - Fee Related
- 1992-08-21 ES ES92402321T patent/ES2074846T3/es not_active Expired - Lifetime
- 1992-08-21 EP EP92402321A patent/EP0530087B1/de not_active Expired - Lifetime
- 1992-08-21 DK DK92402321.1T patent/DK0530087T3/da active
- 1992-08-21 AU AU21251/92A patent/AU646968B2/en not_active Ceased
- 1992-08-21 ZA ZA926328A patent/ZA926328B/xx unknown
- 1992-08-21 AT AT92402321T patent/ATE122035T1/de not_active IP Right Cessation
- 1992-08-21 NZ NZ244051A patent/NZ244051A/en unknown
- 1992-08-21 CA CA002076589A patent/CA2076589C/fr not_active Expired - Fee Related
- 1992-08-21 DE DE69202313T patent/DE69202313T2/de not_active Expired - Fee Related
- 1992-08-21 JP JP4222710A patent/JPH0780831B2/ja not_active Expired - Lifetime
-
1993
- 1993-04-27 US US08/053,911 patent/US5385944A/en not_active Expired - Fee Related
-
1994
- 1994-12-20 US US08/359,879 patent/US5449689A/en not_active Expired - Fee Related
- 1994-12-20 US US08/359,605 patent/US5449690A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU646968B2 (en) | 1994-03-10 |
US5389683A (en) | 1995-02-14 |
DK0530087T3 (da) | 1995-10-02 |
DE69202313T2 (de) | 1996-01-25 |
NZ244051A (en) | 1995-02-24 |
US5449690A (en) | 1995-09-12 |
AU2125192A (en) | 1993-02-25 |
FR2680507B1 (fr) | 1993-10-08 |
FR2680507A1 (fr) | 1993-02-26 |
JPH0780831B2 (ja) | 1995-08-30 |
US5449689A (en) | 1995-09-12 |
DE69202313D1 (de) | 1995-06-08 |
EP0530087B1 (de) | 1995-05-03 |
JPH0692926A (ja) | 1994-04-05 |
US5385944A (en) | 1995-01-31 |
CA2076589A1 (en) | 1993-02-24 |
EP0530087A1 (de) | 1993-03-03 |
ES2074846T3 (es) | 1995-09-16 |
CA2076589C (fr) | 1998-08-11 |
ZA926328B (en) | 1993-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE122035T1 (de) | Naphthylethylharnstoff und naphthylethylthioharnstoff verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
ATE145904T1 (de) | Isochinolin-5-yl-sulfonsäureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
ATE174920T1 (de) | Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
ATE144503T1 (de) | Thiazolidin-2,4-dionderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
ATE113585T1 (de) | Aminsäure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE160344T1 (de) | Heterozyklische alkylamine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten | |
DE59010312D1 (de) | 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel | |
AU656466B2 (en) | New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
ATE164578T1 (de) | Verzweigte aminothiazole-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthalten | |
ATE160338T1 (de) | Alpha aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE152707T1 (de) | Neue naphthalin-amide und sulfonamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
ATE193531T1 (de) | Phenyl-carboxamide-isoxazole-derivate und salze, verfahren zu ihrer herstellung ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen die sie enthalten | |
ATE172976T1 (de) | 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE66209T1 (de) | Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. | |
ATE118212T1 (de) | 1-(alkoxybenzyl)piperazineamide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE25679T1 (de) | Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung. | |
ATE144510T1 (de) | N-(isochinolein-5-yl)-sulfonyl azazykloalkane, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
ATE170520T1 (de) | Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE26577T1 (de) | 1-0-alkyl-3-amino-propan-1.2-diol-2-0phospholipide, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
ATE113598T1 (de) | Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ATE193703T1 (de) | N-benzylpiperazinverbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen | |
ATE123776T1 (de) | Aminoalkylchromone, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen. | |
ATE32063T1 (de) | Iminosulfonamide und verfahren zu ihrer herstellung, die pharmazeutische praeparate solche verbindungen enthalten, sowie die verbindungen zur verwendung. | |
ATE153995T1 (de) | Cyclizierte analoge der fettsäurenmetaboliten, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATA52288A (de) | Malonsaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung, enthaltend diese verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |